{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:58:42Z","timestamp":1772765922553,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11596-024-2895-x","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T12:25:30Z","timestamp":1720700730000},"page":"726-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["LncRNA MEG3 Inhibits the Epithelial-mesenchymal Transition of Bladder Cancer Cells through the Snail\/E-cadherin Axis"],"prefix":"10.1007","volume":"44","author":[{"given":"Liang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-cheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"issue":"3","key":"2895_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021,71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2895_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.21037\/tau.2020.02.24","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen Y, Xin S, et al. Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030. Transl Androl Urol, 2020,9(2):153\u2013165","journal-title":"Transl Androl Urol"},{"issue":"10061","key":"2895_CR3","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet, 2016,388(10061):2796\u20132810","journal-title":"Lancet"},{"issue":"4","key":"2895_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4103\/0970-1591.166445","volume":"31","author":"S Isharwal","year":"2015","unstructured":"Isharwal S, Konety B. Non-muscle invasive bladder cancer risk stratification. Indian J Urol, 2015,31(4):289\u2013296","journal-title":"Indian J Urol"},{"key":"2895_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12935-019-0893-z","volume":"19","author":"J Zhang","year":"2019","unstructured":"Zhang J, Gao Y. Long non-coding RNA MEG3 inhibits cervical cancer cell growth by promoting degradation of P-STAT3 protein via ubiquitination. Cancer Cell Int, 2019,19:175","journal-title":"Cancer Cell Int"},{"issue":"16","key":"2895_CR6","doi-asserted-by":"publisher","first-page":"jcs244020","DOI":"10.1242\/jcs.244020","volume":"133","author":"A Gong","year":"2020","unstructured":"Gong A, Zhao X, Pan Y, et al. The lncRNA MEG3 mediates renal cell cancer progression by regulating ST3Gal1 transcription and EGFR sialylation. J Cell Sci, 2020,133(16):jcs244020","journal-title":"J Cell Sci"},{"issue":"2","key":"2895_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/jcp.29025","volume":"235","author":"G Shan","year":"2020","unstructured":"Shan G, Tang T, Xia Y, et al. MEG3 interacted with miR-494 to repress bladder cancer progression through targeting PTEN. J Cell Physiol, 2020,235(2):1120\u20131128","journal-title":"J Cell Physiol"},{"issue":"3","key":"2895_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1039\/c2mb25386k","volume":"9","author":"L Ying","year":"2013","unstructured":"Ying L, Huang Y, Chen H, et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst, 2013,9(3):407\u2013411","journal-title":"Mol Biosyst"},{"key":"2895_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.omtn.2019.01.014","volume":"16","author":"C Huang","year":"2019","unstructured":"Huang C, Liao X, Jin H, et al. MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion. Mol Ther Nucleic Acids, 2019,16:51\u201362","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2895_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1074\/jbc.M116.750950","volume":"292","author":"M Terashima","year":"2017","unstructured":"Terashima M, Tange S, Ishimura A, et al. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines. J Biol Chem, 2017,292(1):82\u201399","journal-title":"J Biol Chem"},{"issue":"12","key":"2895_CR11","doi-asserted-by":"publisher","first-page":"22947","DOI":"10.1002\/jcp.28856","volume":"234","author":"J Li","year":"2019","unstructured":"Li J, Jiang X, Li C, et al. LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1\/RNF2 in cholangiocarcinoma. J Cell Physiol, 2019,234(12):22947\u201322959","journal-title":"J Cell Physiol"},{"issue":"10","key":"2895_CR12","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1248\/bpb.b23-00156","volume":"46","author":"M Wang","year":"2023","unstructured":"Wang M, Tu Y, Liu C, et al. Gambogenic Acid Inhibits Invasion and Metastasis of Melanoma through Regulation of lncRNA MEG3. Biol Pharm Bull, 2023,46(10):1385\u20131393","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"2895_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol, 2019,29(3):212\u2013226","journal-title":"Trends Cell Biol"},{"issue":"2","key":"2895_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer, 2013,13(2):97\u2013110","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2895_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1158\/1541-7786.MCR-16-0331","volume":"15","author":"G Luo","year":"2017","unstructured":"Luo G, Liu D, Huang C, et al. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27(Kip1). Mol Cancer Res, 2017,15(7):789\u2013799","journal-title":"Mol Cancer Res"},{"issue":"2","key":"2895_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41419-018-0264-z","volume":"9","author":"M Wang","year":"2018","unstructured":"Wang M, Guo C, Wang L, et al. Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription. Cell Death Dis, 2018,9(2):238","journal-title":"Cell Death Dis"},{"issue":"1","key":"2895_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41556-018-0196-y","volume":"21","author":"MP Stemmler","year":"2019","unstructured":"Stemmler MP, Eccles RL, Brabletz S, et al. Non-redundant functions of EMT transcription factors. Nat Cell Biol, 2019,21(1):102\u2013112","journal-title":"Nat Cell Biol"},{"key":"2895_CR18","doi-asserted-by":"publisher","first-page":"28587","DOI":"10.1038\/srep28587","volume":"6","author":"S Imani","year":"2016","unstructured":"Imani S, Hosseinifard H, Cheng J, et al. Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Sci Rep, 2016,6:28587","journal-title":"Sci Rep"},{"issue":"2","key":"2895_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2007.11.151","volume":"367","author":"F Vesuna","year":"2008","unstructured":"Vesuna F, van Diest P, Chen JH, et al. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun, 2008,367(2):235\u2013241","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2895_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/gutjnl-2011-301576","volume":"61","author":"G Schneider","year":"2012","unstructured":"Schneider G, Kramer OH, Saur D. A ZEB1-HDAC pathway enters the epithelial to mesenchymal transition world in pancreatic cancer. Gut, 2012,61(3):329\u2013330","journal-title":"Gut"},{"issue":"6","key":"2895_CR21","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","volume":"7","author":"J Comijn","year":"2001","unstructured":"Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell, 2001,7(6):1267\u20131278","journal-title":"Mol Cell"},{"issue":"2","key":"2895_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol, 2000,2(2):76\u201383","journal-title":"Nat Cell Biol"},{"issue":"9","key":"2895_CR23","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1002\/cmdc.201300534","volume":"9","author":"A Bhan","year":"2014","unstructured":"Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem, 2014,9(9):1932\u20131956","journal-title":"ChemMedChem"},{"issue":"9","key":"2895_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/15680096113136660102","volume":"13","author":"Y Wang","year":"2013","unstructured":"Wang Y, Shi J, Chai K, et al. The Role of Snail in EMT and Tumorigenesis. Curr Cancer Drug Targets, 2013,13(9):963\u2013972","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"2895_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00441-014-1953-2","volume":"358","author":"ZC Liu","year":"2014","unstructured":"Liu ZC, Chen XH, Song HX, et al. Snail regulated by PKC\/GSK-3beta pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells. Cell Tissue Res, 2014,358(2):491\u2013502","journal-title":"Cell Tissue Res"},{"issue":"1","key":"2895_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers10010001","volume":"10","author":"J Cicenas","year":"2017","unstructured":"Cicenas J, Zalyte E, Rimkus A, et al. JNK, p38, ERK, and SGK1 Inhibitors in Cancer. Cancers (Basel), 2017,10(1):1","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2895_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3892\/or.2021.7991","volume":"45","author":"X Wang","year":"2021","unstructured":"Wang X, Li X, Wang Z. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes. Oncol Rep, 2021,45(4):40","journal-title":"Oncol Rep"},{"issue":"6","key":"2895_CR28","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/tox.23109","volume":"36","author":"H Zhan","year":"2021","unstructured":"Zhan H, Chang X, Wang X, et al. LncRNA MEG3 mediates nickel oxide nanoparticles-induced pulmonary fibrosis via suppressing TGF-beta1 expression and epithelial-mesenchymal transition process. Environ Toxicol, 2021,36(6):1099\u20131110","journal-title":"Environ Toxicol"},{"issue":"2","key":"2895_CR29","first-page":"dev194027","volume":"148","author":"TL Dill","year":"2021","unstructured":"Dill TL, Carroll A, Pinheiro A, et al. The long noncoding RNA Meg3 regulates myoblast plasticity and muscle regeneration through epithelial-mesenchymal transition. Development, 2021,148(2):dev194027","journal-title":"Development"},{"issue":"2","key":"2895_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA: New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol, 2019,20(2):69\u201384","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"20","key":"2895_CR31","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.3390\/ijms21207624","volume":"21","author":"I Kaszak","year":"2020","unstructured":"Kaszak I, Witkowska-Pilaszewicz O, Niewiadomska Z, et al. Role of Cadherins in Cancer-A Review. Int J Mol Sci, 2020,21(20):7624","journal-title":"Int J Mol Sci"},{"issue":"35","key":"2895_CR32","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","volume":"37","author":"AM Mendonsa","year":"2018","unstructured":"Mendonsa AM, Na TY, Gumbiner BM. E-cadherin in contact inhibition and cancer. Oncogene, 2018,37(35):4769\u20134780","journal-title":"Oncogene"},{"key":"2895_CR33","doi-asserted-by":"publisher","first-page":"25798","DOI":"10.1038\/srep25798","volume":"6","author":"Y Pan","year":"2016","unstructured":"Pan Y, Li J, Zhang Y, et al. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression. Sci Rep, 2016,6:25798","journal-title":"Sci Rep"},{"issue":"2","key":"2895_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0968-0004(98)01343-7","volume":"24","author":"G Christofori","year":"1999","unstructured":"Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci, 1999,24(2):73\u201376","journal-title":"Trends Biochem Sci"},{"key":"2895_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","volume":"126","author":"M Canel","year":"2013","unstructured":"Canel M, Serrels A, Frame MC, et al. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci, 2013,126 (Pt 2):393\u2013401","journal-title":"J Cell Sci"},{"issue":"11","key":"2895_CR36","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.2174\/13816128113199990512","volume":"20","author":"Y Lin","year":"2014","unstructured":"Lin Y, Dong C, Zhou BP. Epigenetic regulation of EMT: the Snail story. Curr Pharm Des, 2014,20(11):1698\u20131705","journal-title":"Curr Pharm Des"},{"issue":"10","key":"2895_CR37","doi-asserted-by":"publisher","first-page":"e0139790","DOI":"10.1371\/journal.pone.0139790","volume":"10","author":"J Zhu","year":"2015","unstructured":"Zhu J, Liu S, Ye F, et al. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells. PLoS One, 2015,10(10):e0139790","journal-title":"PLoS One"},{"issue":"3","key":"2895_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm757","volume":"3","author":"MA Nieto","year":"2002","unstructured":"Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol, 2002,3(3):155\u2013166","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"14","key":"2895_CR39","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1128\/MCB.23.14.5078-5089.2003","volume":"23","author":"D Dominguez","year":"2003","unstructured":"Dominguez D, Montserrat-Sentis B, Virgos-Soler A, et al. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol Cell Biol, 2003,23(14):5078\u20135089","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2895_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00418-012-0998-0","volume":"138","author":"J Schulte","year":"2012","unstructured":"Schulte J, Weidig M, Balzer P, et al. Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem Cell Biol, 2012,138(6):847\u2013860","journal-title":"Histochem Cell Biol"},{"issue":"4","key":"2895_CR41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00428-018-2310-8","volume":"472","author":"R Santi","year":"2018","unstructured":"Santi R, Cai T, Nobili S, et al. Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study. Virchows Arch, 2018,472(4):605\u2013613","journal-title":"Virchows Arch"},{"issue":"7","key":"2895_CR42","doi-asserted-by":"publisher","first-page":"166401","DOI":"10.1016\/j.bbadis.2022.166401","volume":"1868","author":"Y Yan","year":"2022","unstructured":"Yan Y, Bao G, Pei J, et al. NF-kappaB and EGFR participate in S1PR3-mediated human renal cell carcinomas progression. Biochim Biophys Acta Mol Basis Dis, 2022,1868(7):166401","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2895_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2019.02.003","volume":"142","author":"B Peng","year":"2019","unstructured":"Peng B, He R, Xu Q, et al. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway. Pharmacol Res, 2019,142:1\u201313","journal-title":"Pharmacol Res"},{"issue":"1","key":"2895_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13046-021-01828-7","volume":"40","author":"Y Lee","year":"2021","unstructured":"Lee Y, Ko D, Yoon J, et al. TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity. J Exp Clin Cancer Res, 2021,40(1):58","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2895-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T22:13:56Z","timestamp":1733868836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2895-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2895"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2895-x","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"assertion":[{"value":"26 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}